glp-1 bipolar Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry GLP-1 Medications for Weight Loss

its activation in this tissue may therefore suggest increased or more efficient respiratory function in treated animals

By end user, the retail pharmacies segment held the dominating share of 51% in the market in 2025

[DOI] [PubMed] [Google Scholar] 87.Husain M., Birkenfeld A.L., Donsmark M., Dungan K., Eliaschewitz F.G., Franco D.R., Jeppesen O.K., Lingvay I., Mosenzon O., Pedersen S.D., et al

Multidistrict Litigation helps reduce the plaintiffs costs and expenses, aids in efficient pursuit of the claims, and allows for uniform pre-trial decisions from a single judge

Pharmacogenomic research suggests that genetic differences may affect GLP-1 treatment response

A similar study reported that berberine treatment significantly elevates the number of GLP-1 positive L cells in mice